2m 2m 2m 2m 2m 2m 2m
ANI Pharmaceutic (ANIP)
NASDAQ
$75.37+$0.02 (+0.03%)
Price as of Aug 21, 2026 7:39 PM EDT- $1.7BMarket Cap
- -17.21%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ANI Pharmaceutic (ANIP)
$75.37+$0.02 (+0.03%)
ANIP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $75.35 | ||
Change | -$1.97 (-2.55%) | ||
Open | $77.33 | ||
High | $77.81 | ||
Low | $74.81 | ||
Previous Close | $77.32 | ||
Volume | 379,162 | ||
30-Day Average Volume | 351,982 | ||
1-Week Change | -1.55% | ||
1-Month Change | -4.80% | ||
1-Year Change | -17.21% | ||
3-Year Change | 23.10% | ||
5-Year Change | 169.49% | ||
Fundamentals | |||
Shares Outstanding | 23.0M | ||
Total Assets | $1.5B | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $266.0M | ||
Net Income | $24.7M | ||
Free Cash Flow | $53.6M | ||
EBIT | $40.7M | ||
EBITDA | $60.4M | ||
Net Working Capital | $541.8M | ||
EPS | $1.05 | ||
Enterprise Value/EBITDA | 28 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 3 | ||
P/E | 72 | ||
PEG | -4 | ||
Price/Free Cash Flow | 32 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/04/2012 | ||
Earnings & Revenue